Correlation Between X4 Pharmaceuticals and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Spyre Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Spyre Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Spyre Therapeutics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between XFOR and Spyre is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Spyre Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Spyre Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, X4 Pharmaceuticals is 2.56 times less risky than Spyre Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Spyre Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 323.00 in Spyre Therapeutics on August 27, 2024 and sell it today you would earn a total of 2,447 from holding Spyre Therapeutics or generate 757.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Spyre Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Spyre Therapeutics |
X4 Pharmaceuticals and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Spyre Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
| Spyre Therapeutics vs. Inter Parfums | Spyre Therapeutics vs. Kontoor Brands | Spyre Therapeutics vs. Vince Holding Corp | Spyre Therapeutics vs. Lincoln Electric Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |